Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme

BackgroundLong noncoding RNAs (lncRNAs) can act as competitive endogenous RNAs (ceRNAs) to compete with mRNAs for binding miroRNAs (miRNAs). The dysregulated triplets, composed by mRNAs, lncRNAs, and miRNAs, contributed to the development and progression of diseases, such as cancer. However, the roles played by triplet biomarkers are not fully understand in glioblastoma multiforme (GBM) patient survival.ObjectivesHere, we constructed a differential triplet interaction network (TriNet) between GBM and normal tissues and identified GBM survival related triplets.MethodsFour significantly dysregulated modules, enriched differentially expressed molecules, were identified by integrating affinity propagation method and hypergeometric method. Furthermore, knockdown of TP73-AS1 was implemented by siRNA and the expression of RFX1 was examined in U87 cells by qRT-PCR. The apoptosis of U87 cells was investigated using MTT assay and Acridine orange/Ethidium bromide (AO/EB) assay.ResultsWe randomly split GBM samples into training and testing sets, and found that these four modules can robustly and significantly distinguish low- and high-survival patients in both two sets. By manually curated literatures for triplets mediated by core interactions, we found that members involved tumor invasion, proliferation, and migration. The dysregulated triplets may cause the poor survival of GBM patients. We finally experimentally verified that knockdown of TP73-AS1, an lncRNA of one triplet, could not only reduce the expression of RFX1, an mRNA of this triplet, but also induce apoptosis in U87 cells.ConclusionsThese results can provide further insights to understand the functions of triplet biomarkers that associated with GBM prognosis.

[1]  Nectarios Koziris,et al.  TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support , 2011, Nucleic Acids Res..

[2]  T. Wakabayashi,et al.  Current Trends in Targeted Therapies for Glioblastoma Multiforme , 2012, Neurology research international.

[3]  Ulrich Bodenhofer,et al.  APCluster: an R package for affinity propagation clustering , 2011, Bioinform..

[4]  R. DePinho,et al.  PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis. , 2013, Cell reports.

[5]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[6]  Pengjun Wang,et al.  Overexpression of the long non‐coding RNA MEG3 impairs in vitro glioma cell proliferation , 2012, Journal of cellular biochemistry.

[7]  O. Topolcan,et al.  New molecularly targeted therapies for glioblastoma multiforme. , 2012, Anticancer research.

[8]  Hui Zhou,et al.  starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data , 2010, Nucleic Acids Res..

[9]  Phillip A Sharp,et al.  Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition. , 2014, Molecular cell.

[10]  Tao Xi,et al.  FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity , 2014, FEBS letters.

[11]  C. Wahlestedt,et al.  Emerging treatment strategies for glioblastoma multiforme , 2014, EMBO molecular medicine.

[12]  Jia Yu,et al.  Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression , 2015, Journal of experimental & clinical cancer research : CR.

[13]  I. Chiu,et al.  Regulation of FGF1 Gene Promoter through Transcription Factor RFX1 , 2010, The Journal of Biological Chemistry.

[14]  Scott B. Dewell,et al.  Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.

[15]  S. Nicolaidis.  Biomarkers of glioblastoma multiforme. , 2015, Metabolism: clinical and experimental.

[16]  Ming Sun,et al.  Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer , 2014, Molecular Cancer.

[17]  Vikram Agarwal,et al.  Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. , 2014, Molecular cell.

[18]  D. Trafalis,et al.  Glioblastoma multiforme: Pathogenesis and treatment. , 2015, Pharmacology & therapeutics.

[19]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[20]  Kotb Abdelmohsen,et al.  LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR , 2016, Nucleic acids research.

[21]  George A Calin,et al.  MicroRNAs and ceRNAs: therapeutic implications of RNA networks , 2014, Expert opinion on biological therapy.

[22]  L. J. Lee,et al.  Targeted delivery of tumor suppressor microRNA-1 by transferrin-conjugated lipopolyplex nanoparticles to patient-derived glioblastoma stem cells. , 2014, Current pharmaceutical biotechnology.

[23]  R. Penzel,et al.  FAM96A is a novel pro‐apoptotic tumor suppressor in gastrointestinal stromal tumors , 2015, International journal of cancer.

[24]  Ravi Sirdeshmukh,et al.  Towards developing biomarkers for glioblastoma multiforme: a proteomics view , 2014, Expert review of proteomics.

[25]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[26]  Z. Dong,et al.  Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma , 2016, Oncotarget.

[27]  Xia Li,et al.  Comparison of long non-coding RNAs, microRNAs and messenger RNAs involved in initiation and progression of esophageal squamous cell carcinoma , 2014, Molecular medicine reports.

[28]  Ming Cui,et al.  microRNAs and ceRNAs: RNA networks in pathogenesis of cancer. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[29]  Yang Li,et al.  HMDD v2.0: a database for experimentally supported human microRNA and disease associations , 2013, Nucleic Acids Res..

[30]  Meng Li,et al.  Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells* , 2014, The Journal of Biological Chemistry.

[31]  G. Condorelli,et al.  Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. , 2015, Circulation research.

[32]  J. Harrow,et al.  GENCODE: producing a reference annotation for ENCODE , 2006, Genome Biology.

[33]  Matthias A. Karajannis,et al.  Glioblastoma multiforme: State of the art and future therapeutics , 2014, Surgical neurology international.

[34]  K. Becker,et al.  The Genetic Association Database , 2004, Nature Genetics.

[35]  R. Beijersbergen,et al.  A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation , 2011, The Journal of experimental medicine.

[36]  Fabian J Theis,et al.  Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer , 2015, Molecular Cancer.

[37]  Jian Zhang,et al.  Cancer Specific Long Noncoding RNAs Show Differential Expression Patterns and Competing Endogenous RNA Potential in Hepatocellular Carcinoma , 2015, PloS one.

[38]  Ning Liu,et al.  Long Non-Coding RNA H19 Promotes Glioma Cell Invasion by Deriving miR-675 , 2014, PloS one.

[39]  K. Urbańska,et al.  Glioblastoma multiforme – an overview , 2014, Contemporary oncology.

[40]  I. Irminger-Finger,et al.  Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs. , 2014, The international journal of biochemistry & cell biology.

[41]  Astrid Lægreid,et al.  Gastrin-induced proliferation involves MEK partner 1 (MP1) , 2013, In Vitro Cellular & Developmental Biology - Animal.

[42]  P. Pandolfi,et al.  Aberrant ceRNA activity drives lung cancer , 2014, Cell Research.

[43]  G. Nikkhah,et al.  LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program , 2013, Oncotarget.

[44]  R. Giegerich,et al.  Fast and effective prediction of microRNA/target duplexes. , 2004, RNA.

[45]  Xing Chen,et al.  LncRNADisease: a database for long-non-coding RNA-associated diseases , 2012, Nucleic Acids Res..

[46]  Z. Du,et al.  MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway , 2014, Cancer science.

[47]  M. Gorospe,et al.  Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.

[48]  Myriam Gorospe,et al.  Functional interplay between RNA-binding protein HuR and microRNAs. , 2012, Current protein & peptide science.

[49]  S. Srivastava,et al.  Prostate cancer: Diagnostic performance of the PCA3 urine test , 2011, Nature Reviews Urology.

[50]  Guang-Ming Xu,et al.  MicroRNA-197 inhibits cell proliferation by targeting GAB2 in glioblastoma. , 2016, Molecular medicine reports.

[51]  T. Wilson.  Glioblastoma – A tale of two tumors: Case comparison and literature review , 2014, Surgical neurology international.

[52]  Mohammad Mohammadianpanah,et al.  Treatment outcome and prognostic factors of adult glioblastoma multiforme. , 2013, Journal of the Egyptian National Cancer Institute.

[53]  H. Fine,et al.  Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date , 2015, Cancer.

[54]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[55]  T. Kawase,et al.  Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning , 2004, Oncogene.

[56]  Kotb Abdelmohsen,et al.  Functional interactions among microRNAs and long noncoding RNAs. , 2014, Seminars in cell & developmental biology.

[57]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[58]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[59]  Michael Kertesz,et al.  The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.

[60]  Martin Reczko,et al.  DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs , 2012, Nucleic Acids Res..

[61]  W. Filipowicz,et al.  Properties of the Regulatory RNA-Binding Protein HuR and its Role in Controlling miRNA Repression. , 2011, Advances in experimental medicine and biology.